Author:
Ings R.M.J.,Gray A.J.,Taylor A.R.,Gordon B.H.,Breen M.,Hiley M.,Brownsill R.,Marchant N.,Richards R.,Wallace D.,Hughes T.,Thomas R.,Williams J.,Lucas C.,Campbell D.B.
Reference11 articles.
1. Phase I clinical study of the new amino acid-linked nitrosourea, S10036, administered on a weekly schedule;Khayat;Cancer Res,1987
2. Quantitative assessment of hepatic function by breath analysis after oral administration of 14C-aminopyrine;Hepner;Ann Intern Med,1975
3. A comparison of numerical integrating algorithms by trapezoid, lagrange and spline approximations;Yeh;J Pharmacokinet Biopharm,1978
4. A new method for the measurement of nitrosoureas in plasma: an h.p.l.c. method for the measurement of fotemustine kinetics;Gordon;Xenobiotica,1989
5. Main metabolite of 1-(2-chloroethyl-3-[1′-(5-p-nitrobenzoyl-2′-3′-isopropylidene)-α,β-D-ribofuranosyl-]-1-nitrosourea and 1-(2-chloroethyl)-3-(2′,3′,4′-Tri-O-acetyl-α,β-D-ribofuranosyl)-1-nitrosourea in rats;Madelmont;Drug Metab Dispos,1982
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献